Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3671970

CCCCCCCCC1=C([Zr]C2=C(CCCCCCCC)C=CC2)CC=C1.Cl.Cl

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 2/20 0.33
PTGS2 known ✓ P35354 3/20 0.32
ESR1 known ✓ P03372 2/20 0.32
ADRA2A known ✓ P08913 2/20 0.32
SLC6A2 known ✓ P23975 2/20 0.32
SLC6A4 known ✓ P31645 2/20 0.32
SLC6A3 known ✓ Q01959 2/20 0.32
KCNH2 known ✓ Q12809 2/20 0.32
ADRB3 known ✓ P13945 1/20 0.32
HTR2C known ✓ P28335 1/20 0.32
EGFR known ✓ P00533 1/20 0.32
LCK known ✓ P06239 1/20 0.32
CHRM2 known ✓ P08172 1/20 0.32
CHRM5 known ✓ P08912 1/20 0.32
CHRM1 known ✓ P11229 1/20 0.32
ADRA2B known ✓ P18089 1/20 0.32
ADRA2C known ✓ P18825 1/20 0.32
CHRM3 known ✓ P20309 1/20 0.32
PTGS1 known ✓ P23219 1/20 0.32
MAPK14 known ✓ Q16539 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL616916 1.00 ACHE (0.33) ACHEBACE1PTGS2ESR1ADRA2A
Hydrochloric Acid SCHEMBL7082368 1.00 ACHE (0.33) ACHEBACE1PTGS2ESR1ADRA2A
Hydrochloric Acid SCHEMBL1685599 1.00 ACHE (0.33) ACHEBACE1PTGS2ESR1ADRA2A
Hydrochloric Acid SCHEMBL5359567 1.00 ACHE (0.33) ACHEBACE1PTGS2ESR1ADRA2A
Hydrochloric Acid SCHEMBL21854564 1.00 ACHE (0.33) ACHEBACE1PTGS2ESR1ADRA2A
Hydrochloric Acid SCHEMBL3682820 0.98 ACHE (0.30) ACHEBACE1
SCHEMBL27485462 0.98 ACHE (0.33) ACHEBACE1PTGS2ESR1ADRA2A
SCHEMBL821696 0.98 ACHE (0.33) ACHEBACE1PTGS2ESR1ADRA2A
SCHEMBL8147082 0.98 ACHE (0.33) ACHEBACE1PTGS2ESR1ADRA2A
SCHEMBL822442 0.98 ACHE (0.33) ACHEBACE1PTGS2ESR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517928-B1 SUPPORTED HYBRID METALLOCENE CATALYST, METHOD FOR PREPARING THE SAME, AND METHOD FOR PREPARING POLYOLEFIN USING THE SAME LG CHEMICAL LTD (KR) 2010-11-10 EP disclosed
US-7294600-B2 Supported hybrid metallocene catalyst, method for preparing the same, and method for preparing polyolefin using the same LG CHEM, LTD. (KR) 2007-11-13 US disclosed
US-7247595-B2 Supported metallocene catalyst and olefin polymerization using the same LG CHEM, LTD. (KR) 2007-07-24 US disclosed
EP-1016689-B1 Olefin thermoplastic elastomer compositions MITSUI CHEMICALS INC (JP) 2007-03-07 EP disclosed
US-20060235171-A1 Supported hybrid metallocene catalyst, method for preparing the same, and method for preparing polyolefin using the same LG CHEM, LTD. (KR) 2006-10-19 US disclosed
US-20060135351-A1 Supported metallocene catalyst and olefin polymerization using the same LG CHEM, LTD. (KR) 2006-06-22 US disclosed
US-7041618-B2 Supported metallocene catalyst and olefin polymerization using the same LG CHEMICAL LTD. (KR) 2006-05-09 US disclosed
EP-1390374-B1 SUPPORTED POLYMERIZATION CATALYST USING A CATALYST PRECUSOR HAVING FUNCTIONAL GROUP AND SURFACE MODIFIED CARRIER AND OLEFIN POLYMERIZATION USING THE SAME LG CHEMICAL LTD (KR) 2006-03-01 EP disclosed
US-6908877-B2 Supported polymerization catalyst using a catalyst precursor having functional group and surface modified carrier and olefin polymerization using the same LG CHEM. LTD. (KR) 2005-06-21 US disclosed
EP-1057867-B1 RESIN DISPERSION, METHOD OF PREPARING THE SAME, RESIN-COATED METAL SHEET OBTAINED WITH THE SAME, AND PROCESS FOR PRODUCING LAMINATE MITSUI CHEMICALS INC (JP) 2005-04-20 EP disclosed
EP-0751182-A1 Olefin thermoplastic elastomer compositions MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1997-01-02 EP disclosed
US-5567777-A CONTAINING AN ALPHA-OLEFIN; TRANSPARENCY MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1996-10-22 US disclosed
US-5567776-A BLEND ELASTOMERIC COPOLYMERS CONTAINING ALPHA- AND CYCLO-OLEFINS; IMPACT STRENGTH, TRANSPARENCY, FIBER OPTICS MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1996-10-22 US disclosed
EP-0691354-A1 Unsaturated copolymer of ethylene and process for preparing the same MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1996-01-10 EP disclosed
US-5470919-A Seals with ozone resistance, heat aging resistance, oil resistance and weatherproofing MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1995-11-28 US disclosed
EP-0638594-A1 Chlorinated ethylene/alpha-olefin copolymer rubber and composition containing the same MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1995-02-15 EP disclosed
EP-0597119-A1 CYCLOOLEFIN COPOLYMER COMPOSITION AND PRODUCTION THEREOF MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1994-05-18 EP disclosed
EP-0303519-B1 POLYMERIZATION OF ETHYLENE MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1993-03-31 EP disclosed
US-4931517-A Polymerization of ethylene MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) 1990-06-05 US disclosed
EP-0303519-A1 Polymerization of ethylene MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1989-02-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135351-A1 Supported metallocene catalyst and olefin polymerization using the same MCM4, OSBP, POF1B ACHE 832/4885PTGS2 1139/4885ESR1 570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.